Commenting April 4 on topics discussed by the Medicare Payment Advisory Commission in March, AHA said it continues to strongly oppose additional site-neutral payment cuts to hospital outpatient departments, which need stable and adequate government reimbursements to ensure access to care in this highly challenging financial environment. AHA also urged the commission to maintain the average-sales-price-plus-6% payment methodology for Medicare Part B drugs; and raised concerns about a proposed alternative to Medicare’s wage index system.

“For many hospitals and health systems, continued financial viability is becoming increasingly difficult as they manage the aftermath of the most significant public health crisis in a century, as well as the incredible challenges of deepening workforce shortages, broken supply chains and historic levels of inflation that have increased the costs of caring for patients,” AHA wrote. “Now more than ever, hospitals need stable and adequate government reimbursements in order to ensure access to care in this highly challenging environment.”

Perspective
Public
Approximately 35 million Americans are enrolled in Medicare Advantage plans in 2026, and that number is expected to grow to about 45 million MA enrollees by…
Headline
The Centers for Medicare & Medicaid Services has released details on downloading its upcoming fiscal year 2025 Program for Evaluating Payment Patterns…
Headline
The Department of Health and Human Services Administration for Community Living has launched the first phase of its Health at Home Challenge, a competition to…
Headline
The AHA shared the following statement with the media in response to a report released May 7 by Families USA.   “This report is long on rhetoric and…
Headline
The AHA May 7 wrote to House and Senate lawmakers in support of the Medicare Advantage Improvement Act (H.R. 8375/S. 4384), bipartisan and bicameral…
Headline
The Centers for Medicare & Medicaid Services announced May 6 that it will provide access to certain glucagon-like peptide-1 (GLP-1) medications to eligible…